Everscale vs Enzyme — how do they compare? Everscale trades at Rp169.86 (market cap Rp334,77M, Rp2,11M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Everscale is far larger — about 2.5× Enzyme's market cap, and Everscale's circulating supply is 2B EVER versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Everscale for 5 Days and Enzyme for 29 Days on average.
| EVER | MLN | |
|---|---|---|
Market Cap | Rp334,77M | Rp134,13M |
Volume (24h) | Rp2,11M | Rp104,56M |
Circulating Supply | 2B EVER | 3,3M MLN |
Typical Hold Time | 5 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Everscale (EVER) currently shows limited market activity with a market cap of Rp334.77 million and circulating supply of 2 million tokens. The asset demonstrates minimal trading volume and network activity, with a short average hold time of 5 days suggesting speculative trading patterns. Technical indicators show the token trading in a narrow range with low volatility, while fundamental metrics indicate subdued on-chain activity and ecosystem development.
Outlook remains cautious due to low liquidity and limited adoption. Key opportunities include potential ecosystem growth and network upgrades, while major risks involve high volatility in thin markets, regulatory uncertainty for blockchain projects, and competition from established layer-1 protocols. Investors should monitor exchange listings and developer activity for catalysts.
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
Everscale is a secure and fast layer-one blockchain designed to be a decentralized platform for high-performance applications with real-world relevance, such as stablecoins, CBDCs, DEXs, bridges, Gaming platforms, and more.
Read more on EVER →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →